Ginsenoside Rg1 alleviates Aβ deposition by inhibiting NADPH oxidase 2 activation in APP/PS1 mice

Background: Ginsenoside Rg1 (Rg1), an active ingredient in ginseng, may be a potential agent for the treatment of Alzheimer’s disease (AD). However, the protective effect of Rg1 on neurodegeneration in AD and its mechanism of action are still incompletely understood. Methods: Wild type (WT) and APP/...

Descripció completa

Dades bibliogràfiques

Autors principals:	Han Zhang, Yong Su, Zhenghao Sun, Ming Chen, Yuli Han, Yan Li, Xianan Dong, Shixin Ding, Zhirui Fang, Weiping Li, Weizu Li
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2021-11-01
Col·lecció:	Journal of Ginseng Research
Matèries:	Ginsenoside Rg1 Aβ deposition NADPH oxidase 2 APP/PS1 mice Alzheimer’s disease
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S1226845321000361
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!